Immix Biopharma raises ~$93.7M net via 19.1M share and warrant offering at $5.10

Immix Biopharma, Inc.

19,117,646 shares at $5.10/share and 490,196 pre-funded warrants at $5.09/warrant in underwritten offering.
Net proceeds expected ~$93.7M after underwriting discounts and estimated expenses.
Underwriting agreement with Morgan Stanley & Co. LLC as representative of underwriters.
Offering expected to close December 9, 2025, subject to customary closing conditions.
Pre-funded warrants exercisable immediately at $0.01/share, with 4.99% beneficial ownership limitation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.